Skip to content

The Metabolic Effects of a High Fructose Versus a High Glucose Diet in Overweight Men

The Metabolic Effects of a High Fructose Versus a High Glucose Diet in Overweight Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01050140
Enrollment
32
Registered
2010-01-15
Start date
2010-01-31
Completion date
2011-04-30
Last updated
2012-07-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Status, Hepatic Fatty Acid Metabolism, Oxidative Stress, Systemic Insulin Resistance

Keywords

fructose, fatty liver disease, diet

Brief summary

Dietary consumption of fructose has increased by nearly 50% since 1960. A high fructose diet (HFrD) results in greater visceral adiposity and systemic insulin resistance than a high glucose diet. The effects of fructose on liver fatty acid and ATP stores, systemic oxidative stress and cardiovascular status are not fully known.

Detailed description

The protocol will assess the following outcomes: 1. The ultimate fate of this increased hepatic fatty acid production following a high fructose vs. glucose diet 2. The effect of a high fructose vs. glucose diet on liver ATP stores 3. The effect of a high fructose vs. glucose diet on markers of oxidative stress 4. The effect of a high fructose vs. glucose diet on cardiovascular status Factors critical to carbohydrate metabolism such as systemic insulin resistance, body composition, energy expenditure, physical activity will also be assessed. 32 centrally overweight healthy males with a low baseline fructose intake will be recruited. They will be randomised double blindly to receive 25% of their dietary energy requirements from either fructose or glucose for 14 days. The sugars will first be taken in an energy balanced and then an overfeeding setting.

Interventions

DIETARY_SUPPLEMENThigh sugar diet

25% of dietary energy from fructose or glucose

Sponsors

University of Nottingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. Body mass index 25-32 2. Waist \> hip circumference 3. Age 18-50 years 4. Male

Exclusion criteria

1. Reported weight change \> 3 kg in prior 3/12 2. Active health problems 3. Contraindications to MRI scanning 4. Symptoms of functional bloating or irritable bowel syndrome 5. Abnormal liver or renal function tests 6. Random glucose greater than 11.0 mmol/L 7. Evidence of metabolic or viral liver disease as screened for by hepatitis B and C serology, and ferritin. 8. Alcohol intake \> 21 units per week 9. Vegetarianism 10. Normal daily fructose intake from drinks greater than that in 500ml of coca cola 11. Abnormal carbohydrate energy contribution to baseline diet - defined as greater than 2 standard deviations from the mean of the National Diet and Nutrition Survey 2002 data

Design outcomes

Primary

MeasureTime frame
Liver triglyceride content2 weeks

Secondary

MeasureTime frame
Total abdominal visceral fat content (MRI)2 weeks
Liver ATP, PME concentration and pH (31P MRS)2 weeks
Liver de novo lipogenesis2 weeks
Muscle triglyceride content2 weeks
Hepatic and systemic insulin resistance2 weeks
Cardiovascular measures using finometry2 weeks
Systemic oxidative stress and inflammatory cytokine profile2 weeks
Resting energy expenditure, lipid and carbohydrate oxidation rates2 weeks

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 23, 2026